Evaluation of early-onset cardiotoxic effects of anthracyclines used during the treatment of childhood acute lymphoblastic leukemia by speckle-tracking echocardiography

OBJECTIVE: Anthracyclines are widely used in the treatment of acute lymphoblastic leukemia (ALL). However, cardiotoxicity is the most critical side effect that requires dose limitation. It is thought to occur at first exposure, but the clinical presentation may occur years later. In this study, we a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilir, Özlem Arman, Çetin, İbrahim İlker, Kaçar, Dilek, Aker, Can Barış, Özbek, Namık Yaşar, Yaralı, Neşe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Cardiology 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878936/
https://www.ncbi.nlm.nih.gov/pubmed/34927587
http://dx.doi.org/10.5152/AnatolJCardiol.2021.926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878936/
https://www.ncbi.nlm.nih.gov/pubmed/34927587
http://dx.doi.org/10.5152/AnatolJCardiol.2021.926

Ejemplares similares